Abpro Holdings Inc (ABP)

May 27, 2025

Nasdaq Top 5 Premarket Gainers: Clik Holdings, Graphjet Technology, NuCana, Ekso Bionics Holdings, Abpro Holdings - MSN

May 27, 2025

May 16, 2025

Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga

May 16, 2025

May 15, 2025

Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga

May 15, 2025

May 09, 2025

Financial Fitness Check: Examining Abpro Holdings Inc (ABP)’s Key Ratios - DWinneX

May 09, 2025

May 02, 2025

Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 By Investing.com - Investing.com India

May 02, 2025

May 01, 2025

Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 - Investing.com Australia

May 01, 2025

Apr 30, 2025

ABP stock plunges to 52-week low, touches $0.23 - Investing.com

Apr 30, 2025

Apr 30, 2025

Holdings of Abpro Holdings Inc (ABP) are aligned with the stars - Sete News

Apr 30, 2025

Apr 30, 2025

Closing Strong: Abpro Holdings Inc (ABP) Ends at 0.26, Down -0.27 from Last Close - DWinneX

Apr 30, 2025

Apr 29, 2025

Abpro Holdings Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025

Apr 28, 2025

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - ADVFN

Apr 28, 2025

Apr 28, 2025

ABP’s Stock Journey: What Investors Need to Know About Abpro Holdings Inc’s Performance - investchronicle.com

Apr 28, 2025

Apr 28, 2025

Analyzing ABP’s price-to-book ratio for the last quarter - uspostnews.com

Apr 28, 2025

Apr 28, 2025

Abpro Holdings Presents Promising Preclinical Cancer Data - TipRanks

Apr 28, 2025

Apr 28, 2025

Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 28, 2025

Apr 27, 2025

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager - The Manila Times

Apr 27, 2025

Apr 27, 2025

Abpro and Celltrion Reveal Promising Preclinical Data for Bispecific T-Cell Engager ABP-102/CT-P72 Targeting HER2-Positive Cancers - Nasdaq

Apr 27, 2025

Apr 27, 2025

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing - Bluefield Daily Telegraph

Apr 27, 2025

Apr 27, 2025

Cancer Drug Shows 2X Better Tumor Suppression in Breakthrough Study | ABP Stock News - Stock Titan

Apr 27, 2025

Apr 25, 2025

Abpro Holdings CEO Acquires Additional Shares - TradingView

Apr 25, 2025

Apr 25, 2025

Stocks in play: A&W Food Services of Canada Inc - The Globe and Mail

Apr 25, 2025

Apr 24, 2025

Abpro Holdings amends convertible note terms with Yorkville - Investing.com

Apr 24, 2025

Apr 16, 2025

ABP stock plunges to 52-week low, touches $0.23 By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 15, 2025

Abpro Holdings identifies errors, to restate prior financials By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Abpro Holdings identifies errors, to restate prior financials - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

Abpro Holdings, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Apr 09, 2025

Abpro Holdings approves significant stock issuance to Yorkville - Investing.com Australia

Apr 09, 2025

Apr 08, 2025

Abpro Holdings approves significant stock issuance to Yorkville By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

Abpro Holdings faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

Abpro Holdings faces Nasdaq delisting over share price - Investing.com

Apr 08, 2025

Apr 01, 2025

Abpro Holdings Delays Year-End Financial Report - TipRanks

Apr 01, 2025

Mar 26, 2025

Abpro Holdings to Present Preclinical Data at AACR 2025 - TipRanks

Mar 26, 2025

Mar 25, 2025

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - The Manila Times

Mar 25, 2025

Mar 25, 2025

Groundbreaking Cancer Treatment Data: Abpro's HER2 Therapy Selected for Major AACR Showcase - Stock Titan

Mar 25, 2025

Mar 11, 2025

Abpro Chief Executive Ian Chan Departs -March 11, 2025 at 04:42 am EDT - Marketscreener.com

Mar 11, 2025

Mar 11, 2025

Abpro Statement on the Departure of Former CEO Ian Chan - The Manila Times

Mar 11, 2025

Mar 10, 2025

Abpro Advances Potential Best-in-Class HER2 Cancer Treatment Amid Leadership Change - Stock Titan

Mar 10, 2025

Mar 06, 2025

3 Stocks Primed for Compounding Wealth This Decade - The Globe and Mail

Mar 06, 2025

Mar 05, 2025

Why Oil and Gas Giants ExxonMobil, Chevron, and ConocoPhilips Were Down Today on an Up Day for the Market - The Globe and Mail

Mar 05, 2025

Mar 04, 2025

Reaction to Tariffs Was as Expected - The Globe and Mail

Mar 04, 2025

Mar 03, 2025

European and U.S. Futures Rise Amid Optimism Over Inflation Data and Tariff Developments - The Globe and Mail

Mar 03, 2025

Mar 03, 2025

Design Software Stocks Q4 Teardown: Adobe (NASDAQ:ADBE) Vs The Rest - The Globe and Mail

Mar 03, 2025